- Home
- JPM vs LLY Comparison
JPM vs LLY Comparison
Compare JPM & LLY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
HOLD
Current Price
$1,080.90
Company Overview
Basic Information| Metric | JPM | LLY |
|---|---|---|
| Founded | 1799 | 1876 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 879.5B | 950.7B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | JPM | LLY |
|---|---|---|
| Price | $323.33 | $1,080.90 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 13 | 18 |
| Target Price | $329.46 | ★ $1,084.06 |
| AVG Volume (30 Days) | ★ 9.4M | 3.1M |
| Earning Date | 01-13-2026 | 02-05-2026 |
| Dividend Yield | ★ 1.85% | 0.64% |
| EPS Growth | 12.35 | ★ 121.02 |
| EPS | 20.18 | ★ 20.44 |
| Revenue | ★ $167,229,000,000.00 | $59,419,800,000.00 |
| Revenue This Year | $11.53 | $42.86 |
| Revenue Next Year | $3.92 | $20.29 |
| P/E Ratio | ★ $16.04 | $52.77 |
| Revenue Growth | 3.13 | ★ 45.41 |
| 52 Week Low | $202.16 | $623.78 |
| 52 Week High | $330.86 | $1,111.99 |
Technical Indicators
Market Signals| Indicator | JPM | LLY |
|---|---|---|
| Relative Strength Index (RSI) | 57.62 | 65.07 |
| Support Level | $312.22 | $1,068.30 |
| Resistance Level | $330.86 | $1,085.50 |
| Average True Range (ATR) | 5.46 | 24.09 |
| MACD | 0.72 | -0.30 |
| Stochastic Oscillator | 76.76 | 93.19 |
Price Performance
Historical Comparison JPM
LLY
About JPM JP Morgan Chase & Co.
JPMorgan Chase is one of the largest and most complex financial institutions in the United States, with more than $4 trillion in assets. It is organized into four major segments: consumer and community banking, corporate and investment banking, commercial banking, and asset and wealth management. JPMorgan operates and is subject to regulation in multiple countries.
About LLY Eli Lilly and Company
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.